Literature DB >> 2459041

Appalachian spring: variations on ancient gastro-entero-pancreatic themes in New World mammals.

S Seino1, C D Blackstone, S J Chan, J Whittaker, G I Bell, D F Steiner.   

Abstract

Studies of guinea pig genomic and/or cDNA clones encoding the gastro-entero-pancreatic (GEP) hormones--insulin, glucagon and pancreatic polypeptide--as well as portions of the insulin receptor, are described. Multiple clustered substitutions (localized rapid mutation acceptance) altering the biological properties of both insulin and glucagon have been revealed, but this does not appear to be the case with either pancreatic polypeptide or those regions of guinea pig insulin receptor cDNAs that have been examined thus far. These findings suggest that novel selective pressures operative in the New World environment, in which these animals evolved in isolation from Old World mammalian species, have led to altered solutions to problems related to the regulation of growth and carbohydrate metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459041     DOI: 10.1055/s-2007-1010853

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Donald F. Steiner MD, 1930-2014: discoverer of proinsulin.

Authors:  Louis H Philipson; Graeme Bell; Kenneth S Polonsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

Review 2.  Hexokinase binding to mitochondria: a basis for proliferative energy metabolism.

Authors:  S G Golshani-Hebroni; S P Bessman
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 3.  Evolution of the Insulin Gene: Changes in Gene Number, Sequence, and Processing.

Authors:  David M Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-02       Impact factor: 5.555

4.  Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.

Authors:  David M Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.